eVai Platform
Diagnosis of Rare Genetic Diseases
CommercialActive
Key Facts
About EnGenome
EnGenome is a private, revenue-generating diagnostics company founded in 2011 as a spin-off from the University of Pavia. It has developed the IVDR-certified eVai platform, an AI-powered software-as-a-service (SaaS) solution for the interpretation of genomic variants, primarily targeting the rare disease diagnostic market. The company combines a strong academic foundation with a commercial focus, achieving regulatory milestones and expanding its cloud-based services across Europe.
View full company profile